AR024715A1 - Enmascaramiento del sabor de preparaciones liquidas de quinolona orales usando resinas de intercambio ionico - Google Patents

Enmascaramiento del sabor de preparaciones liquidas de quinolona orales usando resinas de intercambio ionico

Info

Publication number
AR024715A1
AR024715A1 ARP000103565A ARP000103565A AR024715A1 AR 024715 A1 AR024715 A1 AR 024715A1 AR P000103565 A ARP000103565 A AR P000103565A AR P000103565 A ARP000103565 A AR P000103565A AR 024715 A1 AR024715 A1 AR 024715A1
Authority
AR
Argentina
Prior art keywords
ion exchange
exchange resins
oral
quinolona
flavor
Prior art date
Application number
ARP000103565A
Other languages
English (en)
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of AR024715A1 publication Critical patent/AR024715A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulacion de productos líquidos orales de quinolonas o derivados de las mismas empleando resinas de intercambio ionico, tales como polímero de ácidometacrílico entrecruzado con divinilbenceno, como portador, eliminando de este modo el extremo saboramargo de la formulacion líquida oral de quinolonas.
ARP000103565A 1999-07-14 2000-07-27 Enmascaramiento del sabor de preparaciones liquidas de quinolona orales usando resinas de intercambio ionico AR024715A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35354999A 1999-07-14 1999-07-14

Publications (1)

Publication Number Publication Date
AR024715A1 true AR024715A1 (es) 2002-10-23

Family

ID=23389610

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103565A AR024715A1 (es) 1999-07-14 2000-07-27 Enmascaramiento del sabor de preparaciones liquidas de quinolona orales usando resinas de intercambio ionico

Country Status (24)

Country Link
EP (1) EP1200129B1 (es)
JP (2) JP2003504416A (es)
AR (1) AR024715A1 (es)
AT (1) ATE411047T1 (es)
AU (1) AU777993B2 (es)
BG (1) BG65656B1 (es)
BR (1) BR0012439A (es)
CA (1) CA2378894C (es)
CY (1) CY1108801T1 (es)
CZ (1) CZ302919B6 (es)
DE (1) DE60040540D1 (es)
DK (1) DK1200129T3 (es)
ES (1) ES2313897T3 (es)
HU (1) HUP0202229A3 (es)
IL (2) IL147242A0 (es)
MX (1) MXPA02000501A (es)
NO (1) NO20020134D0 (es)
NZ (1) NZ516536A (es)
PL (1) PL202027B1 (es)
PT (1) PT1200129E (es)
SI (1) SI1200129T1 (es)
SK (1) SK287415B6 (es)
WO (1) WO2001005431A1 (es)
ZA (1) ZA200200026B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589955B2 (en) 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
JP5009707B2 (ja) * 2007-07-10 2012-08-22 東和薬品株式会社 不快な味がマスキングされたキノロン系抗菌剤の経口投与用液剤
ES2588008T3 (es) * 2010-05-19 2016-10-28 Astellas Pharma Inc. Composición farmacéutica que contiene solifenacina

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5275820A (en) * 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
DE69224071T2 (de) * 1991-09-17 1998-05-07 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
DE69419281T2 (de) * 1993-04-28 2000-03-23 Takeda Chemical Industries Ltd Geschmacksmaskierte feste Zubereitung und Verfahren zur Herstellung
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
JP2000103730A (ja) * 1998-07-31 2000-04-11 Otsuka Pharmaceut Co Ltd 服用感が改善された医薬組成物

Also Published As

Publication number Publication date
JP2011246497A (ja) 2011-12-08
IL147242A0 (en) 2002-08-14
EP1200129B1 (en) 2008-10-15
SI1200129T1 (sl) 2009-06-30
AU5930200A (en) 2001-02-05
PL202027B1 (pl) 2009-05-29
DE60040540D1 (de) 2008-11-27
AU777993B2 (en) 2004-11-11
WO2001005431A1 (en) 2001-01-25
PT1200129E (pt) 2008-12-17
HUP0202229A3 (en) 2008-10-28
SK287415B6 (sk) 2010-09-07
BG106329A (en) 2002-08-30
ES2313897T3 (es) 2009-03-16
NZ516536A (en) 2003-09-26
EP1200129A1 (en) 2002-05-02
CA2378894C (en) 2005-11-22
IL147242A (en) 2008-12-29
CY1108801T1 (el) 2012-05-23
ZA200200026B (en) 2003-04-02
BR0012439A (pt) 2002-04-02
SK532002A3 (en) 2002-05-09
ATE411047T1 (de) 2008-10-15
CZ302919B6 (cs) 2012-01-18
CZ200271A3 (cs) 2002-04-17
JP2003504416A (ja) 2003-02-04
DK1200129T3 (da) 2009-01-12
MXPA02000501A (es) 2002-07-02
BG65656B1 (bg) 2009-05-29
NO20020134L (no) 2002-01-11
HUP0202229A2 (hu) 2002-11-28
NO20020134D0 (no) 2002-01-11
CA2378894A1 (en) 2001-01-25
PL352183A1 (en) 2003-08-11

Similar Documents

Publication Publication Date Title
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
NO20035763L (no) Tetrahydrokinolinderivater, farmasøytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet.
NO20013736L (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
MX9204625A (es) Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva.
NO20034149L (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
NO20031273D0 (no) Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
YU82702A (sh) Ortosupstituisani amidi antranilne kiseline i njihova primena kao sredstva za lečenje
ID22681A (id) Garam dari turunan asam karboksiolat naftiridin
DK1453810T3 (da) Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til deres fremstilling, deres anvendelse som medikament indeholdende samme
DK0561948T3 (da) Phosphonsyrederivater, der kan anvendes som antiinflammatoriske midler
NO884329D0 (no) Fremgangsmaate for fremstilling av vannfritt, krystallinsk natriumsalt av 5-klor-3-(2-tenoyl)-2-oksindol-1-karboksamid.
AR024715A1 (es) Enmascaramiento del sabor de preparaciones liquidas de quinolona orales usando resinas de intercambio ionico
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
BR0013582A (pt) Agonistas retinóides seletivos para rar
NO167456C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre
IT7830458A0 (it) Prodotti medicinali che le pirrolidine sostituite, contengono. procedimenti per la loro preparazione, loro impiego e
NO913162D0 (no) Farmasoeytisk preparat for behandling av tonsillitt.
IT8320023A0 (it) Carbacicline, procedimento per laloro preparazione e loro impiegocome medicinali.
NO865139D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperazin-1,4-naftalendion-derivater.
NO20012532D0 (no) Semi-hydroklorid av 8-cyan-1-cyklopropyl-7-(1S,6S-2,8- diazabicyklo(4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre
NO900280L (no) Substituerte benzo(b)pyraner, fremgangsmaate for deres fremstilling, deres anvendelse, saa vel som farmasoeytiske preparater paa basis av disse forbindelsene.
NO20021710D0 (no) Anvendelse av 2-amino-3,4-dihydro-kinazoliner for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander
FR2800237B1 (fr) Appareil de pulverisation, notamment pour vegetaux plantes en ligne
FI93008B (fi) Menetelmä bakteerien vastaisten 6-fluori-1,4-dihydrokinol-4-oni-3-karboksyylihappojohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FG Grant, registration